Navigation Links
Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health
Date:8/27/2008

Nationally Recognized Pediatric Heart Center at The Children's Hospital at Montefiore Provides Access for Community to Complete Range of Care and

Specialty Services Newly Recruited Pediatric Cardiology Team Treats Every Heart Condition

NEW YORK, Aug. 27 /PRNewswire-USNewswire/ -- The Children's Hospital at Montefiore (CHAM) is bringing the medical miracle of pediatric heart transplantation to the Bronx, following the recent approval of its transplant center application by the New York State Department of Health. This important approval clears the way for specialists at CHAM, recently ranked among America's top children's hospitals, to treat any congenital or acquired heart abnormality in children and adolescents.

"By adding pediatric heart transplantation to the full range of care we offer our youngest patients, we better meet the significant health needs of our Bronx community," said Steven M. Safyer, MD, president and CEO, Montefiore Medical Center. "The long-standing impact of social, economic and access-to- healthcare issues means children in the Bronx suffer from a disproportionate number of congenital heart abnormalities and other serious conditions. Now they have access to the high quality care they need right in their own community."

CHAM's heart surgery team and heart center program are already established as among the most active in the region treating congenital and acquired heart defects in children. Key to addition of the new pediatric heart transplant capabilities was the recruitment of nationally renowned pediatric cardiologist Daphne Hsu, MD, who joined CHAM as Division Chief of Pediatric Cardiology and Co-Director of the Pediatric Heart Center. She was also appointed Professor of Pediatrics at Montefiore's affiliated medical school, Albert Einstein College of Medicine (Einstein).

In addition to Dr. Hsu, several prominent specialists in pediatric cardiology have recently joined the
'/>"/>

SOURCE Montefiore Medical Center
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Data Support Earlier Suggested Guidance for Levels of Cell-Mediated Immunity in Pediatric Liver Transplant Patients
2. Novare Announces Completion of First Pediatric Single Port Spleen Removal Using RealHand(R) HD Instruments
3. FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months
4. Pediatric Study Finds 21st Century Non-Contact Thermometer as Accurate as Conventional Thermometers
5. Pediatric Researchers Find Possible Master Switch Gene in Juvenile Arthritis
6. Childrens Brain Tumor Foundations Tissue Bank Consortium May Solve Dire Problem in Pediatric Cancer Research
7. Anesiva Announces Publication of Phase 3 Zingo(TM) Data in the Journal Pediatrics
8. Phase 3 Data Regarding Anti-RSV Antibody To Be Presented at Pediatric Academic Societies (PAS) Annual Meeting
9. New Research for Mechanical Support Devices in Pediatrics to Be Released at International Heart and Lung Transplant Meeting
10. MAP Pharmaceuticals Reports Positive Results From Comparative Pharmacokinetic Trial for its Pediatric Asthma Product Candidate
11. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... -- Lee Tran & Liang LLP (LTL), ... and Yik Yak co-founder disputes, announced today ... most promising biotechnology start-ups in the country, Resilience Therapeutics, ... Sabados .  LTL represents Veronica Sara Weiner , ... fellow scientist at the Massachusetts Institute of Technology.      ...
(Date:6/1/2015)... 2015   Regulus Therapeutics Inc . ( ... discovery and development of innovative medicines targeting microRNAs, ... Ph.D. has resigned as President and Chief Executive ... of Directors, effective today, to pursue investment opportunities ... previously served as Chief Medical Officer of Regulus, ...
(Date:6/1/2015)... Pharmaceuticals, Inc. (Nasdaq: MACK ) today announced data for ... a Phase 1 investigator-sponsored study at the University of ... at the 2015 American Society of Clinical Oncology (ASCO) ... Results from this study show a tolerable safety profile ... intravenously.  Based in part on the data ...
Breaking Medicine Technology:Lee Tran & Liang LLP Files Co-Founder Lawsuit against Leading Biotech Start-up Resilience 2Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 2Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 3Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 4Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 2Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 3Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 4Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 5
... DALLAS, Oct. 15 /PRNewswire-FirstCall/ -- ACCESS ... provided an update on its European commercial launch of ... debilitating side effect of radiation treatment and chemotherapy. ... five European countries, having been granted the CE mak ...
... Pharmaceuticals, Inc. announced today that new data confirm that ... of fat absorption in children aged 7-11 years who ... (CF). EPI is a condition resulting from a deficiency ... are necessary to digest nutrients in food. CREON® has ...
Cached Medicine Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians Feedback 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians Feedback 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians Feedback 4CREON(R) (pancrelipase) Delayed-Release Capsules Improves Absorption of Fat in Young Children With Cystic Fibrosis 2CREON(R) (pancrelipase) Delayed-Release Capsules Improves Absorption of Fat in Young Children With Cystic Fibrosis 3CREON(R) (pancrelipase) Delayed-Release Capsules Improves Absorption of Fat in Young Children With Cystic Fibrosis 4CREON(R) (pancrelipase) Delayed-Release Capsules Improves Absorption of Fat in Young Children With Cystic Fibrosis 5CREON(R) (pancrelipase) Delayed-Release Capsules Improves Absorption of Fat in Young Children With Cystic Fibrosis 6
(Date:6/1/2015)... 02, 2015 The National Association ... as a 2015-2016 inductee into its VIP Professional ... this prestigious distinction for leadership in safety, environment, health ... organization exclusively for professional women, boasting more than 700,000 ... pleased to present Lourinda with this important honor,” said ...
(Date:6/1/2015)... (PRWEB) June 02, 2015 The ... Lenita F. Cornett, DSL, LSSBB (C), First Sergeant A ... VIP Woman of the Year Circle. She is recognized ... NAPW is the nation's leading networking organization exclusively for ... 200 operating Local Chapters. , “I'm pleased to recognize ...
(Date:6/1/2015)... York, New York (PRWEB) June 01, 2015 ... ( http://www.testosteronelawsuithub.com/ ) has amended the Case Management ... Inc.’s AndroGel testosterone gel. The Amended Order which ... of Illinois on May 29, 2015, directs the parties ... Court by August 10, 2015 that outlines parameters and ...
(Date:6/1/2015)... D.C. (PRWEB) June 01, 2015 Linda Kincaid, ... and had an irregular heartbeat. At first she thought it ... found out it was much more than that. After going ... disease. Linda admitted she felt afraid about what might happen ... five million Americans are diagnosed with valve disease each year. ...
(Date:6/1/2015)... 2015 EBSCO Health , a ... DynaMed Plus™ , a cross-platform evidence-based clinical decision ... provides clinicians with the ideal blend of evidence and ... , DynaMed Plus is a significant enhancement over ... most frequently updated evidence-based content. DynaMed Plus content is ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Lourinda Willey, Owner and Principal of Lourinda R. Willey LLC, Into its VIP Professional Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Lenita F. Cornett, First Sergeant of the US Military, Into its VIP Professional Woman of the Year Circle 2Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 2Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 3Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 4Health News:A New Online Resource for Those Living with Heart Valve Disease 2Health News:A New Online Resource for Those Living with Heart Valve Disease 3Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 2Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 3Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 4
... fruit flies get high cholesterol and become obese? The same ... too rich in fats. More importantly, according to two ... fruit flies use the same molecular mechanisms as humans to ... of stored fat that contributes to obesity. The findings mean ...
... , ARLINGTON, Va., Dec. 2 ... life that give us meaning, joy and peace, the LIFE ... using the popular photo-sharing Web site flickr.com. The winning photos ... Foundation,s Web site at www.lifehappens.org/wondersphotos . , Contestants ...
... Dec. 2 Aegis Health Group, the nation,s leading ... chief development officer. As a member of Aegis, executive ... the sales and marketing staff as they focus on ... and physician relationships. , To this newly created position, ...
... point to death from TB, not Addison,s, researcher says ... Pride and Prejudice and Emma ... has long been believed, says one British scholar. , Since ... many historians and other experts have believed the cause was ...
... , LONDON, Dec. 2 ... therapies to treat lifestyle disorders. In the near future, the ... therapies and novel drugs to treat such conditions and reduce ... New analysis from Frost & Sullivan ( http://www.pharma.frost.com ), ...
... ... Links Medical Products Inc., an industry leader in healthcare products for hospitals ... Irvine Spectrum. The new facility is located at 9247 Research Drive, Irvine, ... Spectrum plus an assembly and distribution operation in Indio, California. This most ...
Cached Medicine News:Health News:Latest epidemic? High cholesterol, obesity in fruit flies 2Health News:Latest epidemic? High cholesterol, obesity in fruit flies 3Health News:Wonders of Life Photo Contest Winners Announced 2Health News:Wonders of Life Photo Contest Winners Announced 3Health News:Aegis Health Group Hires Pearson Talbert as Chief Development Officer 2Health News:New Light on Jane Austen's Final Chapter 2Health News:Development of Newer Therapies to Treat Lifestyle Disorders and Reduce the Risk of Co-morbidities is Key to the Expansion of the European Lifestyle Disorders Therapeutics Market, Says Frost & Sullivan 2Health News:Development of Newer Therapies to Treat Lifestyle Disorders and Reduce the Risk of Co-morbidities is Key to the Expansion of the European Lifestyle Disorders Therapeutics Market, Says Frost & Sullivan 3Health News:Links Medical Opens New Headquarters, Prepares to Launch Medical-Grade Manuka Honey 2Health News:Links Medical Opens New Headquarters, Prepares to Launch Medical-Grade Manuka Honey 3
Ruschelit® PVC. Magill tip-nasoral. Black positioning ring. High volume/low pressure cuff. X-ray opaque line. Graduated. Single use....
Ruschelit® PVC. Siliconized. Stainless steel spiral reinforced. High volume/low pressure cuff.Connector is permanently fixed into the tube. X-ray opaque. Graduated. Single use. Sterile...
Tube for Right Bronchus - Ruschelit™ PVC. Color coded for easy identification of ports, balloons and 15mm connectors. High volume/low pressure cuffs. With Carina hook. X-ray opaque line. Gradua...
Laser resistant tubes for use with CO2 and KTP Lasers., ,Designed for airway management during laser surgery of the larynx or other areas in close proximity to the trachea....
Medicine Products: